Evidence map›Paper›PMID 37418202›Full record

ArticleAdvances in experimental medicine and biology2023

An Overview.

Xin Li, Caishui Yang, Jun Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xin LiState Key Laboratory of Cognitive Neuroscience and Learning, Faculty of Psychology, Beijing Normal University, Beijing, China.
Caishui YangState Key Laboratory of Cognitive Neuroscience and Learning, Faculty of Psychology, Beijing Normal University, Beijing, China.
Jun WangState Key Laboratory of Cognitive Neuroscience and Learning, Faculty of Psychology, Beijing Normal University, Beijing, China. jun_wang@bnu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays, China has rapidly progressed into an aging society and is faced with huge challenges on public health. Aging is accompanied by the structural and functional alterations in the brain, which leads to the cognitive decline in the elderly and acts as the primary risk factor for dementia. However, the aging brain has not been well understood at a systemic level. This chapter presents the definition of brain health, the aging situation in China, an overview of the BABRI, the purpose of writing this book, and the introductions of the chapters, respectively, which will contribute to knowledge of the underlying mechanisms of healthy and pathological aging of the brain.

Indexed as

Alzheimer DiseaseCognitive DysfunctionAgedAgingBrainHumansRisk FactorsActive agingAging brainAlzheimer’s disease (AD)Beijing Aging Brain Rejuvenation Initiative (BABRI)Brain healthDementia

Identifiers

PMID37418202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.